Intracellular starvation in the insulin resistance syndrome and type II diabetes mellitus

Medical Hypotheses

Volumn 51, Issue 2, 1998, Pages 95-99

  Fournier, A M ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b South Shore Hospital Miami Beach   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTROLYTE TRANSPORT; ENERGY METABOLISM; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031876918     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90100-1     Document Type: Article

References (40)

1. Davidson M B. Clinical implications of insulin resistance syndromes. Am J Med 1995; 99: 420-425.
2. Reaven G M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
3. DeFronzo R A, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
4. Reaven G M. Syndrome X. Clin Diabetes 1994; 12: 32-36.
5. Kaplan N M. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
6. Modan M, Halkin H, Shiomo A et al. Hyperinsulinemia - a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
7. Fournier A M, Gadia M T, Dubrusly D B, Skyler J S, Sosenko J M. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med 1986; 80: 861-864.
8. Kubrusly D B, Goldberg R B, Fournier A M, Skyler J S, Hsia S L, Sosenko J M. Associations between plasma lipoprotein components and glycemia in normal women [abstr]. Clin Res 1984; 32: 225A.
9. Ochand T J, Becker D J, Bates M, Kuller L H, Drash A L. Plasma insulin and lipoprotein concentrations: an atherogenic association. Ann J Epidemiol 1983; 118: 326-337.
10. Laws A, Reaven G M. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 1992; 231: 25-30.
11. Paolisso G, Ferrannini E, Sgambato S et al. Hyperinsulinemia in patients with hypercholesterolemia. J Clin Endocrinol Metab 1992; 75: 1409-1412.
12. Garcia M J, McNamara R M, Gordon T, Kannell W B. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974; 3: 105-111.
13. Klein B E, Cline R, Moss S E. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Public Health 1984; 74: 336-339.
14. Drury P L. Diabetes and arterial hypertension. Diabetologia 1983; 24: 1-9.
15. Ferrannini E, Haffner S M, Mitchell B D, Stern M P. Hyperinsulinaemia: the key of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
16. Fontbonne A, Charles M A, Thibult N et al. Hyperinsulinaemia as a predictor of coronary health disease mortality in a healthy population: the Paris prospective study, 15-year follow-up. Diabetologia 1991; 34: 356-361.
17. Fontbonne A. Epidemiological data on hyperinsulinaemia and vascular disease. Diabetes/Metabolism Rev 1993; 9(Suppl. 1): 13S-17S.
18. Bonora E, Zavaroni I, Alpi O et al. Relationship between blood pressure and plasma in insulin in non-obese and obese non-diabetic subjects. Diabetologia 1987; 30: 719-723.
19. Hack J M, Sowers J R. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991; 91(1A): 11S-21S.
20. Saad M F, Knowler W C, Pettitt D J et al. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90(2): 229-235.
21. Pinkney J H, Mohamed-Ali V, Denver A E et al. Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes. Hypertension 1994; 24(3): 362-367.
22. Reaven G M, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334(6): 374-381.
23. Morris A D, Connell J M. Insulin resistance and essential hypertension mechanisms and clinical implications. Am J Med Sci 1994; 307(suppl. 1): S47-S52.
24. Olefsky J M, Nolan J J. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr 1995; 61(Suppl. 4): 980S-986S.
25. DeFronzo R A. The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165-171.
26. Resnick L M. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 1992; 93(2A): 11S-20S.
27. Boivin A, Montplaisir I, Deshaies Y. Postprandial modulation of lipoprotein lipase in rats with insulin resistance. Am J Physiol 1994; 267(4 Pt 1): E620-E627.
28. Reynisdottir S, Ellerfeldt K, Wahrenberg H et al. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994; 93(6): 2590-2599.
29. Banerji M A, Lebovitz H E. Coronary heart disease risk factor profiles in black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns. Am J Med 1991; 91(1): 51-58.
30. Weinsier R L, James L D, Darnell B E et al. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med 1991; 90(4): 460-468.
31. Manson J E, Willett W C, Stampfer M J et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
32. Hollenberg N K. Evolution of the treatment of hypertension: what really matters in the 1990s? Am J Med 1992; 93(2A): 4S-10S.
33. Weber M A. Hypertension as a risk factor syndrome: therapeutic implications. Am J Med 1993; 94(4A): 24S-31S.
34. Ferrari P, Weidmann P, Shaw S et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91(6): 589-596.
35. Axelsen M, Eliasson B, Joheim E et al. Lipid intolerance in smokers. J Intern Med 1995; 237(5): 449-455.
36. Smith U. Smoking elicits the insulin resistance syndrome: new aspects of the harmful effect of smoking [editorial; comment]. J Intern Med 1995; 237(5): 435-437.
37. 2+ influx. J Nutr 1995; 125(Suppl. 6); 1732S-1737S.
38. Resnick L M. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 1992; 93(2A): 11S-20S.
39. Alexiewicz J M, Kumar D, Smogorzewski M et al. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995; 123: 919-924.
40. Nathan D M. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med 1996; 124(Suppl.): 86-89.